561 related articles for article (PubMed ID: 18512190)
61. 1H NMR spectroscopic imaging of the mouse brain at 9.4 T.
Miyasaka N; Takahashi K; Hetherington HP
J Magn Reson Imaging; 2006 Oct; 24(4):908-13. PubMed ID: 16958063
[TBL] [Abstract][Full Text] [Related]
62. Simultaneous two-voxel localized (1)H-observed (13)C-edited spectroscopy for in vivo MRS on rat brain at 9.4T: Application to the investigation of excitotoxic lesions.
Doan BT; Autret G; Mispelter J; Méric P; Même W; Montécot-Dubourg C; Corrèze JL; Szeremeta F; Gillet B; Beloeil JC
J Magn Reson; 2009 May; 198(1):94-104. PubMed ID: 19289293
[TBL] [Abstract][Full Text] [Related]
63. Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR system.
Orbach DB; Wu C; Law M; Babb JS; Lee R; Padua A; Knopp EA
J Magn Reson Imaging; 2006 Jul; 24(1):16-24. PubMed ID: 16767701
[TBL] [Abstract][Full Text] [Related]
64. Difference spectroscopy using PRESS asymmetry: application to glutamate, glutamine, and myo-inositol.
Snyder J; Thompson RB; Wilman AH
NMR Biomed; 2010 Jan; 23(1):41-7. PubMed ID: 19688783
[TBL] [Abstract][Full Text] [Related]
65. Selective maximization of (31)P MR spectroscopic signals of in vivo human brain metabolites at 3T.
Blenman RA; Port JD; Felmlee JP
J Magn Reson Imaging; 2007 Mar; 25(3):628-34. PubMed ID: 17279535
[TBL] [Abstract][Full Text] [Related]
66. In vivo monitoring of rat brain metabolites during vigabatrin treatment using localized 2D-COSY.
Welch JW; Bhakoo K; Dixon RM; Styles P; Sibson NR; Blamire AM
NMR Biomed; 2003 Feb; 16(1):47-54. PubMed ID: 12577297
[TBL] [Abstract][Full Text] [Related]
67. Proton T1 relaxation times of cerebral metabolites differ within and between regions of normal human brain.
Brief EE; Whittall KP; Li DK; MacKay A
NMR Biomed; 2003 Dec; 16(8):503-9. PubMed ID: 14696008
[TBL] [Abstract][Full Text] [Related]
68. J-difference-edited MRS measures of γ-aminobutyric acid before and after acute caffeine administration.
Oeltzschner G; Zöllner HJ; Jonuscheit M; Lanzman RS; Schnitzler A; Wittsack HJ
Magn Reson Med; 2018 Dec; 80(6):2356-2365. PubMed ID: 29752742
[TBL] [Abstract][Full Text] [Related]
69. High-field localized 1H NMR spectroscopy in the anesthetized and in the awake monkey.
Pfeuffer J; Juchem C; Merkle H; Nauerth A; Logothetis NK
Magn Reson Imaging; 2004 Dec; 22(10):1361-72. PubMed ID: 15707786
[TBL] [Abstract][Full Text] [Related]
70. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
[TBL] [Abstract][Full Text] [Related]
71. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
72. The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy.
Henry ME; Jensen JE; Licata SC; Ravichandran C; Butman ML; Shanahan M; Lauriat TL; Renshaw PF
Psychiatry Res; 2010 Dec; 184(3):171-6. PubMed ID: 21055907
[TBL] [Abstract][Full Text] [Related]
73. Brain tumors: localized H-1 MR spectroscopy at 0.5 T.
Prost R; Haughton V; Li SJ
Radiology; 1997 Jul; 204(1):235-8. PubMed ID: 9205253
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla.
Hattingen E; Pilatus U; Franz K; Zanella FE; Lanfermann H
J Magn Reson Imaging; 2007 Aug; 26(2):427-31. PubMed ID: 17654728
[TBL] [Abstract][Full Text] [Related]
75. Optimized diffusion-weighted spectroscopy for measuring brain glutamate apparent diffusion coefficient on a whole-body MR system.
Valette J; Guillermier M; Besret L; Boumezbeur F; Hantraye P; Lebon V
NMR Biomed; 2005 Dec; 18(8):527-33. PubMed ID: 16177956
[TBL] [Abstract][Full Text] [Related]
76. Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T.
Kakeda S; Korogi Y; Moriya J; Ohnari N; Sato T; Ueno S; Yanagihara N; Harada M; Matsuda T
Psychiatry Res; 2011 Apr; 192(1):55-9. PubMed ID: 21377845
[TBL] [Abstract][Full Text] [Related]
77. Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques.
Wijtenburg SA; Rowland LM; Edden RA; Barker PB
J Magn Reson Imaging; 2013 Aug; 38(2):460-7. PubMed ID: 23292856
[TBL] [Abstract][Full Text] [Related]
78. Assessment of metabolite quantitation reproducibility in serial 3D-(1)H-MR spectroscopic imaging of human brain using stereotactic repositioning.
Langer DL; Rakaric P; Kirilova A; Jaffray DA; Damyanovich AZ
Magn Reson Med; 2007 Oct; 58(4):666-73. PubMed ID: 17899591
[TBL] [Abstract][Full Text] [Related]
79. Regional distributions of brain glutamate and glutamine in normal subjects.
Goryawala MZ; Sheriff S; Maudsley AA
NMR Biomed; 2016 Aug; 29(8):1108-16. PubMed ID: 27351339
[TBL] [Abstract][Full Text] [Related]
80. Fast spectroscopic imaging strategies for potential applications in fMRI.
Mulkern RV; Chen NK; Oshio K; Panych LP; Rybicki FJ; Gambarota G
Magn Reson Imaging; 2004 Dec; 22(10):1395-405. PubMed ID: 15707789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
